期刊文献+

膀胱癌患者血清中Dickkopf-1的表达 被引量:2

Serum Dickkopf-1 in bladder cancer patients
下载PDF
导出
摘要 目的探讨膀胱癌患者手术前后血清中Dickkopf-1(DKK-1)的表达情况,及其与膀胱癌病理特征的联系。方法采用酶联免疫吸附试验(ELISA)测定48例膀胱癌患者(膀胱癌组)和24例输尿管结石或尿道肉阜患者(对照组)血清中DKK-1水平,采用Western免疫印迹法检测膀胱癌肿瘤组织、癌旁组织和正常组织中DKK-1、β-链蛋白的表达情况,同时采用免疫组织化学法检测DKK-1蛋白的表达阳性率。结果膀胱癌组术前的血清DKK-1水平为(8.18±2.83)ng/mL,显著高于术后的(6.06±2.27)ng/mL(P=0.021);且显著高于对照组的(4.86±2.56)ng/mL(P=0.007)。膀胱癌组低级别上皮癌与高级别上皮癌患者间,浅表性膀胱癌与肌层浸润性膀胱癌患者间手术前后的血清DKK-1水平的差异均无统计学意义(P值均>0.05)。膀胱癌组织和癌旁组织的DKK-1相对表达量分别为2.033±0.372、1.816±0.352,均显著高于正常组织的0.976±0.202(P值分别=0.018、0.047)。在膀胱癌组织中的DKK-1蛋白表达量明显高于对照组,且在血管周围组织有升高现象,但在间质中无明显升高。膀胱癌组织中DKK-1阳性率为48%,显著高于对照组的31%(P=0.020)。结论 DKK-1的表达与膀胱癌的发生关系密切,有可能成为一种新的肿瘤标志物,用于对膀胱癌的检测与诊断。 Objective To evaluate the expression of Dickkopf-1(DKK-1)in bladder cancer patients before and after surgery,and to further study its relationship with clinical pathological features.Methods Enzyme linked immunosorbent assay(ELISA)was used to detect serum DKK-1expression of 48cases in bladder cancer group and 24cases in control group.Western blot was used to detect protein expression of DKK-1andβ-catenin in bladder cancer tissues,adjacent tumor tissues and normal tissues.The differences of DKK-1expression between two groups were assayed by immunohiatochemistry,and the results were observed under Leica microscope.Results The preoperative DKK-1level in the bladder cancer group([8.18±2.83]ng/mL)was significantly higher than postoperative level([6.06±2.27]ng/mL,P=0.021)and that in the control group([4.86± 2.56]ng/mL,P =0.007).There were no statistical differences in serum DKK-1levels between primary epithelioma and advanced epithelioma,or between superficial bladder cancer and muscular layer-invasive bladder cancer(P0.05).The relative amount of DKK-1in bladder cancer tissues and adjacent tumor tissues was higher than that in normal tissues(2.033±0.372,1.816±0.352,and 0.976±0.202;P=0.018and 0.047).The protein expression of DKK-1in bladder cancer tissues was significantly higher than that in control group.And DKK1protein levels were elevated in the tissue surrounding blood vessels,but were not significantly increased in interstitial tissue.DKK-1positive rate in bladder cancer tissues was higher that that in normal tissue(48% vs.31%,P=0.020).Conclusion There is a close relationship between the incidence of bladder cancer and DKK1.DKK-1may become a new tumor marker for the detection and diagnosis of bladder cancer.
出处 《上海医学》 CAS CSCD 北大核心 2013年第7期592-595,F0003,共5页 Shanghai Medical Journal
基金 国家自然科学基金资助项目(81000311)
关键词 膀胱癌 DICKKOPF-1 肿瘤标志物 Bladder cancer Dickkopf-1 Tumor marker
  • 相关文献

参考文献1

二级参考文献1

  • 1Qiujin Shen*, Jia Fan*, Xin-Rong Yang*, Yexiong Tan*, Weifeng Zhao*,Wenxin Qin.et al Serum DKK1 as a protein biomarker for the diagnosis ofhepatocellular carcinoma: a large-scale, multicentre study. www.thelancet.com/oncology Published online June 26, 2012 http://dx.doi.org/10.1016/S 1470-2045 ( 12)70233 -4. 被引量:1

共引文献98

同被引文献48

  • 1GOODISON S, ROSSER C J, URQUIDI V. Bladder cancer detection and monitoring: assessment of urine- and blood- based marker tests[J]. Mol Diagn Ther, 2013, 17(2) : 71- 84. 被引量:1
  • 2BLACK P C, BROWN G A, DINNEY C P. Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer[J]. J Clin Oncot, 2006, 24 (35) : 5528-5535. 被引量:1
  • 3VAN RHIJN B W, VAN DER POEL H G, VAN DER KWAST T H. Urine markers for bladder cancer surveillance: a systematic review[J]. Eur Urol, 2005, 47 (6) : 736-748. 被引量:1
  • 4TILKI D, BURGER M, DALBAGNI G, et al. Urine markers for detection and surveillance of non-muscle-invasive bladder cancer[J]. Eur Urol, 2011, 60(3): 484-492. 被引量:1
  • 5BABJUK M, BURGER M, ZIGEUNER R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the .bladder: update 2013[J]. Eur Urol, 2013, 64(4): 639-653. 被引量:1
  • 6LOKESHWAR V B, HABUCHI T, GROSSMAN H B, et al. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers[J]. Urology, 2005, 66(6 Suppl 1): 35-63. 被引量:1
  • 7ODISHO A Y, BERRY A B, AHMAD A E, et al. Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine eytology[J]. Eur Urol, 2013, 63(5) : 936-940. 被引量:1
  • 8HAJDINJAK T. UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing[J]. Urol Oncol, 2008, 26(6): 646-651. 被引量:1
  • 9MATSUYAMA H, IKEMOTO K, EGUCHI S, et al. Copy number aberrations using muhicolour fluorescence in situ hybridization (FISH) for prognostication in non-musele- invasive bladder cancer (NIMBC) [J]. BJU Int, 2014, 113 (4) : 662-667. 被引量:1
  • 10SANCHINI M A, GUNELLI R, NANNI O, et al. Relevance of urine telomerase in the diagnosis of bladder eaneer[J]. JAMA, 2005, 294(16): 2052-2056. 被引量:1

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部